Slingshot members are tracking this event:
Ixekizumab Demonstrates Rapid, Clinically Meaningful Improvements as Early as One Week among Patients with Moderate-to-Severe Plaque Psoriasis
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|LLY||Community voting in process|
Slingshot Insights Explained
Mar 04, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Uncover-2, Uncover-3, Skin Lesions, Plaque Psoriasis, Dermatologic Diseases, Psoriasis Plaques